This article was originally distributed via PRWeb. PRWeb, WorldNow and this Site make no warranties or representations in connection therewith.
SOURCE: AttorneyOne
As Reuters reported on February 5th, 2013 Merck was ordered by federal jury to pay $285,000 in a lawsuit over the risks associated with Fosamax. In light of this news, AttorneyOne, a recognized authority on law, informs that they are now providing advice, including how to get in contact with legal counsel, to people potentially affected by Fosamax side effects. http://www.attorneyone.com/fosamax-lawsuit/
San Diego, CA (PRWEB) March 05, 2013
AttorneyOne.com, a recognized authority on law, updated the website recently and they are now actively providing expert opinion in view of the recent news on Fosamax Lawsuit.
As Reuters reported on February 5th, 2013 Merck was ordered by federal jury to pay $285,000 in a lawsuit over the risks associated with Fosamax (case no. 1:2008cv04119, New York Southern District Court). Fosamax, manufactured by Merck, belongs to the class of drugs known as bisphosphonates. It was approved by the FDA in 1995 and developed to treat post-menopausal osteoporosis and Paget's disease of bone. In the lawsuit plaintiff claims she took Fosamax from 2000 to 2006 and, as a result, she suffers severe and permanent personal injuries to the jaw bone, including osteonecrosis of the jaw.
Court documents indicate that, on February 14th, 2013, there were 975 actions pending in the Fosamax Products Liability Litigation (MDL 1789) in the U.S. District Court for the Southern District of New York alleging osteonecrosis of the jaw (ONJ) and 842 actions pending in the Fosamax Products Liability Litigation (MDL 2243) in the U.S. District Court for the District of New Jersey alleging femur fractures.
Taking into consideration the latest developments, AttorneyOne.com updated the website and, now, can actively provide an expert opinion including how to get in contact with legal counsel easily and inexpensively in case of alleged Fosamax severe complications. Sean Burke, director of Media Relations for AttorneyOne.com, adds that the relevant information illustrates that people continue to file Fosamax lawsuits. "For that reason", he continues, "our focus should squarely fall on getting the word out and assisting people in finding the right legal assistance.”
A study article published in October 2012 by The Journal of Clinical Endocrinology & Metabolism indicated that atypical femur fractures patients while taking bisphosphonates (incl. Fosamax) experienced delayed healing, prodromal pain, and persisting risk of a contralateral and/or other fracture.
AttorneyOne.com has further information on Fosamax lawsuits including how to get in contact with legal counsel.
Headquartered in San Diego, CA Attorney One was founded in 2004 and is not a law firm. They offer a nationwide legal service which helps consumers find the best representation for their legal needs. You can learn more about Attorney One at our website http://www.attorneyone.com. You can also find us on Facebook at http://www.facebook.com/AttorneyOne. Checkout earlier news from us at http://www.prweb.com/releases/2013/3/prweb10482484.htm
For the original version on PRWeb visit: http://www.prweb.com/releases/prweb2013/3/prweb10491738.htm
All content © Copyright 2000 - 2013 WorldNow and KLTV, a Raycom Media Station.
